The TB Portals: an Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and Analysis
Alex Rosenthal(National Institutes of Health), Michael Tartakovsky(National Institutes of Health), Jessica Taaffe(National Institutes of Health), Sharafat Ismayilova(Ministry of Healthcare), Ucha Nanava(National Center for Tuberculosis and Lung Disease), Alena Skrahina(Republican Scientific and Practical Centre of Pulmonology and Tuberculosis), Zaza Avaliani(National Center for Tuberculosis and Lung Disease), Irina Strâmbu(Ministerul Sanatatii), Roxana Mindru(Ministerul Sanatatii), Alexandra Sora(Ministerul Sanatatii), Eric Engle(National Institutes of Health), Sergo Vashakidze(National Center for Tuberculosis and Lung Disease), Michael A. Harris(National Institutes of Health), Sofia Alexandru, Vassili Kovalev(National Academy of Sciences of Belarus), Rafik Abuzarov(Ministry of Healthcare), Darrell E. Hurt(National Institutes of Health), Natalia Shubladze(National Center for Tuberculosis and Lung Disease), Cătălina Ene(Ministerul Sanatatii), Hagigat Gadirova(Ministry of Healthcare), Valeriu Crudu, Eugene Sergueev(National Academy of Sciences of Belarus), Aliaksandr Skrahin(Belarusian State Medical University), Vladzimir Lapitskii(National Academy of Sciences of Belarus), Kurt Wollenberg(National Institutes of Health), Elcan Mammadbayov(Ministry of Healthcare), Eugenia Ghita(Ministerul Sanatatii), İrada Akhundova, Eduard Snezhko(National Academy of Sciences of Belarus), Andrei Gabrielian(National Institutes of Health), Valery Kirichenko(National Academy of Sciences of Belarus), Alyssa Long(National Institutes of Health), Alexandru Muntean(Ministerul Sanatatii), Miron Alexandru Bogdan(Ministerul Sanatatii), Dragoş Zaharia(Ministerul Sanatatii), Victor Spînu(Ministerul Sanatatii), Alexander V. Tuzikov(National Academy of Sciences of Belarus), Mehriban Seyfaddinova(Ministry of Healthcare), Andrei Astrovko(Republican Scientific and Practical Centre of Pulmonology and Tuberculosis)
Cited by 140
Related Papers
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
|The Lancet Infectious Diseases|2017|688
DBAASP v3: database of antimicrobial/cytotoxic activity and structure of peptides as a resource for development of new therapeutics
|Nucleic Acids Research|2020|667
DBAASP v.2: an enhanced database of structure and antimicrobial/cytotoxic activity of natural and synthetic peptides
|Nucleic Acids Research|2015|241
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
|European Respiratory Journal|2019|176
PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis
|Science Translational Medicine|2014|158